HUM

Humana Inc. [HUM] Stock Forecast

Q: What is Humana Inc. stock symbol ?

Humana Inc. is a US stock, located in Louisville of Ky and trading under the symbol HUM

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

HUM Stock Summary

Earnings have grown 11.81% per last year.

Earnings are expected to rise 8.62% next year

The Moving Average Convergence Divergence (MACD) for HUM recently turned positive (within last 10 days).

HUM's dividend payments are well covered by cash flows with cash payout ratio of 15.54%.

EPS has been decreasing for the past 3 years (Yearly statements)

HUM has less than 1 year of cash runway

Top 10 Correlated ETFs

HUM

Top 10 Correlated Stocks

HUM

In the News

01:43 29 Sep 2023 HUM

Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did

Humana's adjusted diluted EPS and free cash flow payout ratios make the dividend very secure. The managed care company's revenue and adjusted diluted EPS both surged in the first half of 2023. Humana's interest coverage ratio of over 13 is part of why it earns investment-grade credit ratings from the major rating agencies.

04:23 29 Sep 2023 HUM

Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains

In the ever-evolving landscape of investing, the spotlight is on the top healthcare stocks to buy on the dip. The healthcare sector is highly known for its robust resilience and incredible growth potential.

11:04 29 Sep 2023 HUM

The 3 Most Undervalued Healthcare Stocks to Buy in September 2023

Healthcare is a sector that has underperformed the broader stock market this year. The S&P 500 Health Care Sector Index is down over 2.50% year-to-date versus a 17% gain in the benchmark S&P 500 index.

03:02 29 Sep 2023 HUM

Here's Why Investors Should Hold Humana (HUM) in Portfolio

Humana (HUM) remains well-poised for growth on the back of an expanding Medicare Advantage membership, upgraded health plan offering suite and solid cash reserves.

12:02 29 Sep 2023 HUM

Humana (HUM) to Provide In-home Care With Primary Care Anywhere

Humana (HUM) enhances its CenterWell brand with the launch of Primary Care Anywhere.

11:18 29 Sep 2023 HUM

Why Humana (HUM) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

05:26 29 Sep 2023 HUM

A Quality Executive Compensation Plan Lowers The Risk Of Investing In Humana

Humana (HUM) is the featured stock in August's Exec Comp Aligned with ROIC Model Portfolio.

12:47 29 Sep 2023 HUM

5 HMO Stocks to Watch Amid Growing Premiums & Membership

Expanding customer base, contract wins and a rapidly growing aging U.S. population will likely drive the performances of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry trends.

12:46 29 Sep 2023 HUM

Humana (HUM) to Bring Enhanced Kidney Care to MA Members

Humana (HUM) makes Interwell's extensive resources available to its MA members grappling with CKD and ESKD, and hence bring about better health outcomes for them.

04:15 29 Sep 2023 HUM

Humana Inc. to Present at the Wells Fargo 2023 Healthcare Conference

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, President and Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at the Wells Fargo Healthcare Conference on Wednesday, September 6, 2023, at 8:00 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana's Investor Relations page at humana.com. The company suggests webcast participants sign on approximately.

HUM Financial details

Company Rating

Buy

Market Cap

61.22B

Income

3.38B

Revenue

98.73B

Book val./share

135.13

Cash/share

252.58

Dividend

4.24

Dividend %

0.86%

Employees

67.1K

Optionable

Yes

Shortable

Yes

Earnings

01 Nov 2023

P/E

18.19

Forward P/E

PEG

9.94

P/S

0.62

P/B

3.65

P/C

1.96

P/FCF

5.03

Quick Ratio

1.16

Current Ratio

1.37

Debt / Equity

0.72

LT Debt / Equity

0.58

EPS (TTM)

26.96

EPS next Y

EPS next Q

5.31

EPS this Y

-4.34%

EPS next Y

EPS next 5Y

-22.42%

EPS last 5Y

12.24%

Revenue last 5Y

10.29%

Revenue Q/Q

0.02%

EPS Q/Q

-22.3%

SMA20

3.15%

SMA50

11.85%

SMA100

-7.53%

Inst Own

92.41%

Inst Trans

0.97%

ROA

ROE

21%

ROC

0.16%

Gross Margin

78%

Oper. Margin

Profit Margin

Payout

12%

Shs Outstand

123.91M

Shs Float

123.61M

Target Price

549.89

52W Range

423.29-571.3

52W High

-13.25%

52W Low

+17.11%

RSI

Rel Volume

0.47

Avg Volume

1.3M

Volume

613.47K

Perf Week

2.18%

Perf Month

1.35%

Perf Quarter

-5.57%

Perf Half Y

-2.29%

Beta

0.662863

Volatility

2.59%, 11.16%

Prev Close

0.36%

Price

495.36

Change

0.5%

HUM Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Revenue per share	413.95	484.04	583.63	645.47	721.67
Net income per share	12.24	20.19	25.47	22.79	21.8
Operating cash flow per share	15.81	39.42	42.66	17.58	35.64
Free cash flow per share	11.35	33.93	35.36	7.35	26.94
Cash per share	89.97	112.09	130.31	128.89	147.19
Book value per share	73.91	89.79	103.84	124.95	118.98
Tangible book value per share	43.78	59.17	67.72	18.43	34.68
Share holders equity per share	73.91	89.79	103.84	124.95	118.98
Interest debt per share	46.97	45.75	54.94	102.15	91.89
Market cap	39.39B	49.13B	54.24B	59.69B	65.91B
Enterprise value	43.28B	50.97B	56.54B	69.12B	72.28B
P/E ratio	23.4	18.15	16.11	20.35	23.49
Price to sales ratio	0.69	0.76	0.7	0.72	0.71
POCF ratio	18.13	9.3	9.62	26.39	14.37
PFCF ratio	25.23	10.8	11.6	63.1	19.01
P/B Ratio	3.88	4.08	3.95	3.71	4.3
PTB ratio	3.88	4.08	3.95	3.71	4.3
EV to sales	0.76	0.79	0.73	0.83	0.78
Enterprise value over EBITDA	15.32	12.6	10.69	16.73	15.01
EV to operating cash flow	19.92	9.65	10.03	30.56	15.76
EV to free cash flow	27.73	11.21	12.1	73.06	20.85
Earnings yield	0.04	0.06	0.06	0.05	0.04
Free cash flow yield	0.04	0.09	0.09	0.02	0.05
Debt to equity	0.61	0.49	0.51	0.8	0.75
Debt to assets	0.25	0.2	0.2	0.29	0.27
Net debt to EBITDA	1.38	0.45	0.44	2.28	1.32
Current ratio	1.34	1.48	1.4	1.22	1.52
Interest coverage	10.51	14.34	16.52	10.48	9.9
Income quality	1.29	1.95	1.67	0.77	1.64
Dividend Yield	0.01	0.01	0.01	0.01	0.01
Payout ratio	0.16	0.11	0.1	0.12	0.14
Sales general and administrative to revenue	0.13	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.16	0.14	0.13	0.25	0.21
Capex to operating cash flow	-0.28	-0.14	-0.17	-0.58	-0.24
Capex to revenue	-0.01	-0.01	-0.01	-0.02	-0.01
Capex to depreciation	-1.15	-1.28	-1.56	-1.85	-1.33
Stock based compensation to revenue	0	0	0	0	0
Graham number	142.67	201.98	243.94	253.14	241.6
ROIC	0.11	0.15	0.16	0.1	0.12
Return on tangible assets	0.08	0.11	0.11	0.09	0.08
Graham Net	-28.39	-23.29	-43.86	-105.22	-58.18
Working capital	3.37B	5.19B	5.29B	3.33B	9.01B
Tangible asset value	6.02B	8.11B	9.28B	5.01B	6.23B
Net current asset value	-1.87B	-955M	-2.88B	-9.84B	-1.5B
Invested capital	0.61	0.49	0.51	0.8	0.75
Average receivables	934.5M	1.04B	1.1B	1.48B	1.74B
Average payables	9.9B	9.06B	11.06B	12.48B	13.65B
Average inventory	-1.78B	-3.69B	-4.54B	-5.88B	-3.25B
Days sales outstanding	6.51	5.94	5.38	7.97	6.58
Days payables outstanding	395.22	492.73	441.4	461.43	417.74
Days of inventory on hand	-172.87	-188.21	-191.58	-234.16	0
Receivables turnover	56.07	61.45	67.8	45.79	55.48
Payables turnover	0.92	0.74	0.83	0.79	0.87
Inventory turnover	-2.11	-1.94	-1.91	-1.56	0
ROE	0.17	0.22	0.25	0.18	0.18
Capex per share	-4.45	-5.49	-7.29	-10.23	-8.7

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric	2022-06-30	2022-09-30	2022-12-31	2023-03-31	2023-06-30
Revenue per share	187.02	180.13	178.59	213.93	214.71
Net income per share	5.5	9.44	-0.1	9.91	7.7
Operating cash flow per share	7.58	66.78	-40.81	53.49	25.49
Free cash flow per share	5.37	64.51	-42.86	51.71	23.38
Cash per share	143.77	210.8	150.76	229.33	252.58
Book value per share	122.43	128.42	121.86	132.61	135.13
Tangible book value per share	31.43	42.85	35.52	58.51	59.02
Share holders equity per share	122.43	128.42	121.86	132.61	135.13
Interest debt per share	105.3	86.4	91.78	97.03	98.91
Market cap	59.22B	61.41B	64.35B	60.68B	55.7B
Enterprise value	67.29B	58.69B	70.72B	58.97B	51.69B
P/E ratio	21.27	12.85	-1.24K	12.24	14.52
Price to sales ratio	2.5	2.69	2.87	2.27	2.08
POCF ratio	61.75	7.27	-12.55	9.08	17.54
PFCF ratio	87.09	7.52	-11.95	9.39	19.13
P/B Ratio	3.82	3.78	4.2	3.66	3.31
PTB ratio	3.82	3.78	4.2	3.66	3.31
EV to sales	2.84	2.57	3.15	2.2	1.93
Enterprise value over EBITDA	46.96	36.27	280.62	31.08	33.01
EV to operating cash flow	70.17	6.94	-13.79	8.82	16.27
EV to free cash flow	98.96	7.19	-13.13	9.12	17.75
Earnings yield	0.01	0.02	0	0.02	0.02
Free cash flow yield	0.01	0.13	-0.08	0.11	0.05
Debt to equity	0.85	0.67	0.75	0.72	0.72
Debt to assets	0.28	0.21	0.27	0.22	0.22
Net debt to EBITDA	5.63	-1.68	25.25	-0.91	-2.56
Current ratio	1.57	1.49	1.52	1.39	1.37
Interest coverage	12.12	13.76	0.32	14.86	11.97
Income quality	1.38	7.09	284.83	5.4	3.32
Dividend Yield	0	0	0	0	0
Payout ratio	0.14	0.08	-7.77	0.08	0.12
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.25	0.21	0.21	0.17	0.17
Capex to operating cash flow	-0.29	-0.03	0.05	-0.03	-0.08
Capex to revenue	-0.01	-0.01	-0.01	-0.01	-0.01
Capex to depreciation	-1.33	-1.35	-1.19	-1.02	-1.17
Stock based compensation to revenue	0	0	0	0	0
Graham number	123.1	165.16	16.84	171.97	152.99
ROIC	0.03	0.05	0	0.05	0.04
Return on tangible assets	0.02	0.03	0	0.03	0.02
Graham Net	-83.73	-125.08	-59.59	-57.16	-56.41
Working capital	9.85B	9.25B	9.01B	10.59B	10.48B
Tangible asset value	3.98B	5.42B	6.23B	7.31B	7.35B
Net current asset value	-4.09B	-6.16B	-1.5B	-610M	-805M
Invested capital	0.85	0.67	0.75	0.72	0.72
Average receivables	3.27B	2.49B	1.64B	2.39B	2.27B
Average payables	15.34B	15.72B	15.25B	15.98B	17.94B
Average inventory	-2.86B	-9.27B	-9.27B	0	0
Days sales outstanding	12.81	6.35	6.71	10.46	4.81
Days payables outstanding	437.86	470.52	103.01	527.16	532.94
Days of inventory on hand	0	-545.23	0	0	0
Receivables turnover	7.02	14.17	13.4	8.61	18.72
Payables turnover	0.21	0.19	0.87	0.17	0.17
Inventory turnover	0	-0.17	0	0	0
ROE	0.04	0.07	0	0.07	0.06
Capex per share	-2.21	-2.28	-2.05	-1.78	-2.12

HUM Dividend History

HUM Frequently Asked Questions

What is Humana Inc. stock symbol ?

Humana Inc. is a US stock , located in Louisville of Ky and trading under the symbol HUM

Is Humana Inc. buy or a sell ?

34 stock analysts have 34 predictions with a medium analyst target price of $533.21. The lowest prediction is $450 and the highest is $652

What is HUM stock prediction ?

What is Humana Inc. stock quote today ?

Humana Inc. stock price is $495.36 today.

Is Humana Inc. stock public?

Yes, Humana Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 1.3M
Market Capitalization 61.22B
Employee 67.1K
CEO Mr. Bruce Dale Broussard
Headquarters Louisville,KY,US
IPO Date 1981-12-31
Website https://www.humana.com

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.